Trelagliptin Succinate

CHEMBL2105754 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

475.5 g/mol

LogP

—

Phase

4

Trelagliptin succinate is the succinate salt form of trelagliptin, a once-weekly DPP-4 inhibitor for type 2 diabetes. See trelagliptin for complete pharmacological details. This salt formulation is used in approved once-weekly oral tablets.

Peso molecular

475,5000 g/mol

TPSA

168,00 Å²

Áreas terapéuticas

Diabetes tipo 2

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O.O=C(O)CCC(=O)O

InChI

InChI=1S/C18H20FN5O2.C4H6O4/c1-22-17(25)8-16(23-6-2-3-15(21)11-23)24(18(22)26)10-13-7-14(19)5-4-12(13)9-20;5-3(6)1-2-4(7)8/h4-5,7-8,15H,2-3,6,10-11,21H2,1H3;1-2H2,(H,5,6)(H,7,8)/t15-;/m1./s1

Molecular Formula

C22H26FN5O6

HBD / HBA

3 / 10

Enlaces Rotables

6

Átomos Pesados

34

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

Trelagliptin succinate is the succinate salt form of trelagliptin, a once-weekly DPP-4 inhibitor for type 2 diabetes. See trelagliptin for complete pharmacological details. This salt formulation is used in approved once-weekly oral tablets.

Yes, Trelagliptin Succinate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105754. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 44183569. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

¿Busca información accesible para el paciente?

Trelagliptin Succinate en PillFYI

Estructura

Datos Rápidos

Fórmula: C22H26FN5O6

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.